Eckert & Ziegler Brazil signs TerThera supply deal for GMP terbium — 161 precursor

Eckert & Ziegler Brazil signed a supply agreement with TerThera for GMP-compliant non-carrier-added terbium-161 precursor. Deal aims to establish a reliable South American supply chain for Tb-161 radioligand therapies, targeting access for Brazilian patients. GMP-grade Tb-161 supply supports local development and clinical evaluation of radiopharmaceutical candidates in Brazil. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2414828_en) on October 13, 2026, and is solely responsible for the information contained therein. (C)